What Is a Not-Taken Rate? How Digital Screening Reduces It
Learn what the not-taken rate means in life insurance, why it costs carriers billions annually, and how digital screening technology is bringing placement rates up.

The not-taken rate insurance digital screening conversation keeps showing up in carrier boardrooms, and for good reason. Somewhere between one in four and one in three life insurance policies that get approved never actually get placed. The applicant applied, the underwriter said yes, and then... nothing. The policy dies on the vine. That gap between approval and placement is called the not-taken rate, and it represents one of the most expensive problems the industry has quietly tolerated for decades.
LIMRA research has consistently shown that the life insurance industry's not-taken rate hovers between 15% and 30% depending on product type, with term products at the higher end. For individual life insurance, that translates to billions in lost premium revenue each year that carriers already spent underwriting resources to approve.
What the not-taken rate actually measures
The not-taken rate is straightforward: it is the percentage of approved policies that the applicant never pays the first premium on. The carrier did the work. The underwriter reviewed the file. The policy got issued. But the applicant walked away before paying.
This is different from a decline rate (where the carrier says no) or a withdrawal rate (where the applicant pulls out during underwriting). The not-taken rate specifically captures the gap after approval, which makes it especially frustrating for carriers because they have already spent the money to underwrite the case.
The distinction matters because each of these drop-off points has different causes and different fixes. Decline rates are about risk selection. Withdrawal rates are about the underwriting experience. Not-taken rates are about something else entirely: the time delay between application and approval creates a window where the applicant's motivation evaporates.
Why applicants walk away after approval
The reasons are surprisingly consistent across carriers and product lines. LIMRA's placement studies and RGA's accelerated underwriting research both point to the same core issue: the traditional underwriting process takes too long, and applicants lose interest or find alternatives during the wait.
Here is what drives the not-taken rate up:
| Factor | How it increases the not-taken rate | Estimated impact on placement |
|---|---|---|
| Long underwriting cycle (30-45 days) | Applicant motivation fades, life circumstances change | Strongest driver; each additional week reduces placement by 3-5% |
| Paramedical exam scheduling | Creates friction and delays; rural areas wait 2+ weeks | Applicants who complete exams within 48 hours place at 2x the rate |
| Rate shopping during wait period | Applicant finds a cheaper or faster competitor | Particularly acute in term markets where products are commoditized |
| Buyer's remorse | Time allows second-guessing of purchase decision | Correlates with face amount; higher coverage = more second-guessing |
| Agent disengagement | Agent moves on to new prospects during the wait | Agent follow-up drops significantly after the 14-day mark |
| Life event changes | Job change, health scare, divorce during underwriting | Unpredictable but compounds with longer cycle times |
The through-line is time. Almost every factor on this list gets worse the longer the underwriting process takes. A carrier that can compress the cycle from 30 days to same-day fundamentally changes the math on every one of these drivers.
The economics of not-taken policies
A not-taken policy is not free. The carrier has already spent real money on that case: agent commissions on the application, paramedical exam fees ($50-150 per exam through providers like ExamOne or APPS), electronic data pulls from Milliman IntelliScript and LexisNexis, underwriter labor, and administrative overhead for policy assembly and issuance.
Munich Re's 2024 research on accelerated underwriting economics estimated that the fully loaded cost of underwriting a single traditional life insurance case runs between $150 and $400 depending on the amount of evidence required. When 20-30% of those approved cases never place, carriers are effectively writing off tens of millions of dollars annually in wasted underwriting spend.
The math gets worse when you factor in opportunity cost. Underwriter capacity is finite. Every hour spent on a case that will not place is an hour not spent on a case that will. High not-taken rates create a drag on the entire underwriting operation, not just the individual cases that fall off.
How digital screening changes the placement equation
Digital health screening attacks the not-taken rate at its root cause: the time gap between application and decision. When an applicant can complete a biometric health assessment on their smartphone in minutes rather than scheduling a paramedical exam days or weeks out, the entire timeline compresses.
The mechanism is simple. Remote photoplethysmography (rPPG) and similar camera-based biometric capture technologies let the applicant self-administer a health screening session from their phone. Cardiovascular signals, respiratory rate, and other biometric markers get captured through the device camera. Concurrently, electronic health record queries, prescription history checks via services like IntelliScript, and Motor Vehicle Report pulls execute through API integrations. The underwriting file assembles itself in minutes instead of weeks.
RGA's research on accelerated underwriting programs found that carriers implementing digital-first screening pathways saw placement rate improvements of 8 to 15 percentage points compared to their traditional underwriting cohorts. The gains were most pronounced in term life products under $1 million in face amount, which is exactly the segment where not-taken rates tend to be highest.
What the data shows about speed and placement
The relationship between underwriting speed and placement rate is not linear. There appears to be a cliff somewhere around the two-week mark where placement rates drop sharply.
| Underwriting turnaround | Approximate placement rate | Not-taken rate |
|---|---|---|
| Same-day decision | 88-95% | 5-12% |
| 1-3 days | 82-90% | 10-18% |
| 1-2 weeks | 72-80% | 20-28% |
| 3-4 weeks | 65-75% | 25-35% |
| 5+ weeks | 55-68% | 32-45% |
These ranges are compiled from multiple industry sources including LIMRA placement studies, Munich Re's accelerated underwriting surveys, and RGA's program experience data. The exact numbers vary by product, distribution channel, and face amount band, but the directional pattern is consistent: faster decisions mean higher placement.
The implication is that shaving a few days off a 30-day process helps, but it does not transform placement rates. The real gains come from collapsing the cycle to hours or minutes, which requires replacing the physical logistics chain of paramedical exams and lab work with digital data collection.
What carriers are doing about it
The industry's response has split into two broad approaches: accelerated underwriting programs that fast-track eligible applicants through a digital pathway, and full digital transformation of the entire underwriting operation.
Accelerated underwriting programs
Most large carriers now offer some form of accelerated underwriting for lower-risk applicants meeting specific criteria (typically age under 50-55, face amount under $1 million, clean MIB and prescription history). These programs use algorithmic triage to identify cases that can be decided without a paramedical exam, relying instead on electronic data sources and, increasingly, biometric capture through digital screening.
The SOA's 2023 research on accelerated underwriting noted that programs using multiple electronic data sources in combination with real-time biometric data achieved both higher throughput and better placement rates than programs relying on data sources alone. The biometric component adds a health assessment layer that replaces the paramedical exam without reintroducing the scheduling friction.
Full digital transformation
A smaller number of carriers are going further, rebuilding their underwriting operations around digital-first data collection for all applicants regardless of risk tier. This approach treats digital screening as the default rather than a fast-track exception. The goal is not just to reduce not-taken rates but to fundamentally change the cost structure of underwriting by eliminating physical evidence collection entirely.
Deloitte's 2023 analysis of the U.S. life insurance value chain found that carriers pursuing full digital transformation of underwriting operations reported 40-60% reductions in per-case underwriting costs alongside the placement rate improvements. The cost reduction comes from eliminating paramedical exam fees, reducing underwriter touch time through automated data assembly, and decreasing the administrative overhead of managing physical evidence collection logistics.
The agent factor
Not-taken rates are not purely a technology problem. Distribution plays a role. The agent or broker who sold the case has a direct influence on whether the applicant follows through after approval.
In the traditional model, the agent's momentum stalls during the underwriting wait. Two weeks pass, then three, then four. The agent has moved on to new prospects. When the approval finally comes through, the agent may not follow up with the same urgency they had at the point of sale. The applicant, already wavering, takes the lack of follow-up as permission to let it go.
Digital screening changes this dynamic by keeping the agent in the loop while the iron is hot. When the underwriting decision comes back in hours instead of weeks, the agent can close the sale in the same sitting or the same day. Several carriers have reported that their agents strongly prefer digital pathways not because of the technology itself but because it lets them get paid faster.
Current Research and Evidence
LIMRA has tracked life insurance placement rates for decades and their data consistently shows the correlation between underwriting speed and policy placement. Their 2024 Individual Life Insurance Placement Activity report documented that policies decided within one week placed at rates 15 to 20 percentage points higher than policies taking more than 30 days.
RGA's ongoing work on accelerated underwriting mortality studies provides evidence that digital triage does not compromise risk selection quality. Their 2024 mortality experience study of accelerated underwriting cohorts showed mortality outcomes within expected ranges, countering the concern that faster underwriting means worse risk selection.
The Society of Actuaries published a 2023 research paper on accelerated underwriting practices that surveyed program design across 15 North American carriers. The study found that placement rate improvement was the second most cited benefit of accelerated underwriting programs, after cycle time reduction. Carriers with the most mature programs (three or more years in production) reported the strongest placement gains, suggesting that refinement of eligibility criteria and data source selection improves over time.
The Future of Not-Taken Rate Reduction
The not-taken rate problem will not be solved by technology alone, but technology is the enabler that makes everything else possible. When underwriting can happen in minutes rather than weeks, every other lever gets more effective: agent follow-up, applicant engagement, competitive positioning.
The trajectory is clear. Carriers that have adopted digital screening pathways are seeing measurable improvements in placement rates. As biometric capture technology matures and more electronic data sources become available through API integrations, the percentage of cases eligible for instant or near-instant decisioning will continue to grow.
The remaining challenge is extending digital pathways to higher-risk and higher-face-amount cases that currently require traditional evidence. This is where emerging biometric technologies, including rPPG-based vital signs capture, have the most potential to expand the addressable market for accelerated underwriting beyond its current eligibility boundaries.
Solutions like Circadify's digital health screening platform are working on exactly this problem, enabling carriers to capture rich biometric data from any applicant's smartphone without scheduling delays or physical appointments.
Frequently Asked Questions
What is a good not-taken rate for life insurance?
Industry benchmarks vary by product type, but most carriers consider a not-taken rate below 15% to be strong performance. Term life products typically run higher (20-30%) than permanent products (10-20%). Carriers with mature digital underwriting programs are pushing their not-taken rates below 10% for eligible applicant cohorts.
How is the not-taken rate different from the lapse rate?
The not-taken rate measures policies that were approved but never placed (the first premium was never paid). The lapse rate measures policies that were placed but later terminated due to non-payment of renewal premiums. They capture different problems at different points in the policy lifecycle. Not-taken is a sales completion issue; lapsation is a retention issue.
Does accelerated underwriting increase anti-selection risk?
This was a common concern when accelerated underwriting programs first launched, but the evidence has been reassuring. RGA's mortality experience studies on accelerated underwriting cohorts have shown results within expected ranges. The key is program design: using multiple electronic data sources and biometric screening to maintain risk selection quality while removing physical evidence requirements.
How much does a not-taken policy cost the carrier?
The fully loaded cost varies by case complexity, but industry estimates put it between $150 and $400 per case for traditional underwriting. This includes paramedical exam fees, electronic data pulls, underwriter labor, and administrative overhead. At a 25% not-taken rate across a book of 100,000 approved policies, that represents $3.75 million to $10 million in wasted underwriting spend annually.
